LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Search

ResMed Inc

Fechado

SetorSaúde

230.97 -0.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

230

Máximo

231.74

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

24.993

61.417

Rendimento de Dividendos

0.89

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+28.31% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.89%

2.40%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-371M

37B

Abertura anterior

231.77

Fecho anterior

230.97

Sentimento de Notícias

By Acuity

28%

72%

65 / 351 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de mar. de 2026, 19:08 UTC

Notícias Principais

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13 de mar. de 2026, 18:48 UTC

Ganhos
Grandes Movimentos do Mercado

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13 de mar. de 2026, 17:10 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13 de mar. de 2026, 17:10 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13 de mar. de 2026, 16:47 UTC

Notícias Principais

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

13 de mar. de 2026, 22:27 UTC

Conversa de Mercado
Notícias Principais

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 de mar. de 2026, 22:13 UTC

Conversa de Mercado
Notícias Principais

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 de mar. de 2026, 22:04 UTC

Conversa de Mercado
Notícias Principais

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 de mar. de 2026, 22:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

13 de mar. de 2026, 20:02 UTC

Conversa de Mercado

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 de mar. de 2026, 19:50 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 de mar. de 2026, 19:35 UTC

Notícias Principais

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13 de mar. de 2026, 19:00 UTC

Conversa de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

13 de mar. de 2026, 18:49 UTC

Notícias Principais

The Iran War Could Upend AI. Here's How. -- Barrons.com

13 de mar. de 2026, 18:24 UTC

Notícias Principais

Impact of Middle East Conflict on TotalEnergies Activities

13 de mar. de 2026, 18:00 UTC

Notícias Principais

Is War Good For the Economy? -- WSJ

13 de mar. de 2026, 17:23 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13 de mar. de 2026, 16:46 UTC

Conversa de Mercado
Notícias Principais

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13 de mar. de 2026, 16:38 UTC

Notícias Principais

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13 de mar. de 2026, 16:34 UTC

Aquisições, Fusões, Aquisições de Empresas

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13 de mar. de 2026, 16:33 UTC

Aquisições, Fusões, Aquisições de Empresas

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13 de mar. de 2026, 16:32 UTC

Aquisições, Fusões, Aquisições de Empresas

EQT Completes Exit From Galderma

13 de mar. de 2026, 16:20 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

13 de mar. de 2026, 16:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de mar. de 2026, 16:15 UTC

Notícias Principais

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

13 de mar. de 2026, 16:11 UTC

Conversa de Mercado

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

13 de mar. de 2026, 16:00 UTC

Notícias Principais

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

13 de mar. de 2026, 15:48 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

28.31% parte superior

Previsão para 12 meses

Média 296.2 USD  28.31%

Máximo 345 USD

Mínimo 265 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

7

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

65 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat